Instant Access with secure payment processing: $235 / One Month $975 / One Year Need an invoice? Group rate? Contact admin@DrugPatentWatch.com

Listing of Drug Product Information by Exclusivity Expiration - 2011

Range: 1 - 5

Applicant Tradename Generic Name NDA Approval Date Exclusivity Expiration Patented / Exclusive Use Alcon PATANASE olopatadine hydrochloride 021861 Apr 15, 2008 Apr 15, 2011 NEW DOSAGE FORM Vernalis APOKYN apomorphine hydrochloride 021264 Apr 20, 2004 Apr 20, 2011 ORPHAN DRUG EXCLUSIVITY New River Pharms VYVANSE lisdexamfetamine dimesylate 021977 Dec 10, 2007 Apr 23, 2011 NEW PATIENT POPULATION New River Pharms VYVANSE lisdexamfetamine dimesylate 021977 Feb 23, 2007 Apr 23, 2011 NEW PATIENT POPULATION Sucampo Pharms AMITIZA lubiprostone 021908 Apr 29, 2008 Apr 28, 2011 NEW STRENGTH

 Complete access available with subscription